A phase II trial shows that pembrolizumab and bevacizumab yield a 54.1% intracranial response rate and a median overall ...

In conclusion, laparoscopic radical prostatectomy represents a promising alternative to traditional open surgery for early ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Dupilumab significantly reduced airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma. Read now.

The management and treatment of prostate cancer is evolving to address unmet patient needs, with advancements spanning from diagnosis ...

CANCER screening rates for breast and colorectal cancer rebounded in 2023, surpassing pre-pandemic levels, according to a ...

A SPECIFIC microbial ratio in the gut microbiome, characterised by a lower Bifidobacterium to Akkermansia ratio, has been ...

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.

A recent study on T cell gene therapy trials shows that while secondary malignancies occur in a small percentage of patients, ...

Inadequate sleep duration and persistent late sleep onset are associated with significant fluctuations in blood glucose ...

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

In this edition, spotlighting the microbiome and cutting-edge healthcare advances, explore insights on gut microbes, ...